← Back to news

S

Seeking Alpha: News RSS Feed

Cytek Biosciences GAAP EPS of -$0.34 misses by $0.30, revenue of $62.1M beats by $3.3M

Starz Entertainment Corp. GAAP EPS of -$1.24 misses by $0.09, revenue of $322.8M beats by $0.64M

DoubleVerify Non-GAAP EPS of $0.31 misses by $0.02, revenue of $205.6M misses by $3.17M

Clipper Realty FFO of $0.04 misses by $0.02, revenue of $37.07M misses by $1.03M

Extendicare FFO of $0.33, revenue of $462M beats by $80.3M

Thryv outlines $461M–$471M SaaS revenue target for 2026 as unified platform strategy advances

Phathom outlines $320M–$345M 2026 revenue guidance as company targets operating profitability

Definitive Healthcare GAAP EPS of -$0.09 misses by $0.03, revenue of $61.5M beats by $1.93M

Arhaus outlines $1.43B–$1.47B 2026 revenue target while advancing showroom expansion and navigating tariffs

Daqo New Energy outlines 2026 polysilicon production target of 140,000–170,000 metric tons amid industry consolidation

MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations

PureCycle Technologies reports Q4 results

ICF International Non-GAAP EPS of $1.47 misses by $0.02, revenue of $444M beats by $3.1M

Coupang's 2025 cyberattack dents Q4 profits

EVERTEC Non-GAAP EPS of $0.93 beats by $0.03, revenue of $244.83M beats by $8M

Kratos Defense & Security Solutions plans $1B common stock offering

Personalis GAAP EPS of -$0.26 beats by $0.03, revenue of $17.35M beats by $0.23M

DiamondRock Hospitality FFO of $0.27 beats by $0.04, revenue of $274.53M beats by $1.15M

TTEC Holdings Non-GAAP EPS of $0.47 beats by $0.11, revenue of $570M beats by $55.47M

Accelerant expects Q4 revenue to be $248 million

Seer GAAP EPS of -$0.29 beats by $0.03, revenue of $4.2M misses by $0.4M

National Health Investors FFO of $1.22 in-line, revenue of $105.8M beats by $10.68M

Morgan Stanley Direct Lending Fund NII of $0.49, total investment income of $96.6M

Talen Energy EPS of -$4.79, revenue of $2.58B beats by $90M

CACI International prices $500M senior notes offering to fund ARKA acquisition

Organogenesis Holdings GAAP EPS of $0.24 beats by $0.03, revenue of $225.1M beats by $52.42M

PubMatic Non-GAAP EPS of $0.29 beats by $0.14, revenue of $80.05M beats by $4.82M

Monster Beverage sees double-digit sales growth as core energy drink demand remains strong

Coterra Energy Non-GAAP EPS of $0.39 misses by $0.08, revenue of $1.95B beats by $60M

BioLife Solutions GAAP EPS of $0.04 beats by $0.06, revenue of $24.76M beats by $0.75M

NetApp Non-GAAP EPS of $2.12 beats by $0.06, revenue of $1.71B beats by $10M

Zscaler Non-GAAP EPS of $1.01 beats by $0.11, revenue of $815.8M beats by $16.88M

Progyny Non-GAAP EPS of $0.48 beats by $0.08, revenue of $318.4M beats by $4.14M

SoundHound AI Non-GAAP EPS of -$0.02 in-line, revenue of $55.06M beats by $1.08M

Howard Marks revisits AI bubble question in new memo

Ormat expects 14.6% revenue growth in 2026 while expanding PPA portfolio and EGS initiatives

Rackspace outlines 6% private cloud revenue growth target for 2026 as AI demand accelerates

ACM Research reiterates 25% revenue growth outlook for 2026 while advancing global expansion

Sable Offshore slides as court denies bid to lift injunction blocking pipeline restart

US Physical Therapy outlines $102M–$106M EBITDA target for 2026 as hospital alliances gain momentum

Perimeter Solutions outlines MMT integration and signals improved earnings power with $652.9M revenue in 2025

Excelerate Energy targets $515M–$545M adjusted EBITDA in 2026 while advancing Iraq and Jamaica platforms

Qt Group Oyj GAAP EPS of $0.73, revenue of EUR 77.1M misses by EUR 11.22M

Starwood Property Trust to buy back up to $400M in shares

Flowco signals $82M–$86M Q1 adjusted EBITDA target as Valiant integration broadens artificial lift suite

Catalyst forecasts 21–26% FIRDAPSE revenue growth in 2026 while expanding AGAMREE market penetration

UMH Properties outlines $0.97–$1.05 normalized FFO per share guidance for 2026 while expanding rental program and acquisitions

Aurinia targets $305M–$315M LUPKYNIS sales for 2026 while advancing aritinercept clinical development

Wendel reports FY results

Hellenic Telecommunications reports Q4 results